|
|
|
| Research progress of biomembrane-biomimetic nanoparticles in drug delivery system |
| TIAN Hao CHEN Shichun HAN Yutong CHEN Fuming MA Aiqing LU Chengyu |
| School of Pharmacy, Guangdong Medical University, Guangdong Province, Dongguan 523808, China |
|
|
|
Abstract Biomembrane-coated nanotechnology is a new biomimetic strategy for nanosystems. In this strategy, various kinds of biological membranes with versatile characteristics are used as functional materials and engineered on the surface of drug-loaded nano cores, which avoids the cumbersome process of traditional chemical methods to modify nanoparticles. Benefit from the camouflage function of biological membranes, the mimetic nanoparticles obtain the natural properties of the original biomembrane with good biocompatibility and characteristics of long circulation and lesion targeting. In the past few years, such biomimetic nanosystems have been successfully applied in drug delivery, showing broad application prospects in the fields of accurate diagnosis and treatment of diseases. This paper reviews the research progress of biomimetic nanoparticles in drug delivery system and prospect the future research.
|
|
|
|
|
|
[1] Kamaly N，Yameen B，Wu J，et al. Degradable controlled-release polymers and polymeric nanoparticles：nechanisms of controlling drug release [J]. Chem Rev，2016，116（4）：2602-2663.
[2] Bobo D，Robinson KJ，Islam J，et al. Nanoparticle-based medicines：a review of FDA-approved materials and clinical trials to date [J]. Pharm Res，2016，33（10）：2373-2387.
[3] Cheng W，Nie J，Xu L，et al. PH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy [J]. ACS Appl Mater Interfaces，2017，9（22）：18462-18473.
[4] Yeh CY，Hsiao JK，Wang YP，et al. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer [J]. Biomaterials，2016，99：1-15.
[5] Saei AA，Yazdani M，Lohse SE，et al. Nanoparticle surface functionality dictates cellular and systemic toxicity [J]. Chem Mater，2017，29（16）：6578-6595.
[6] Fang RH，Jiang Y，Fang JC，et al. Cell membrane-derived nanomaterials for biomedical applications [J]. Biomaterials，2017，128：69-83.
[7] Kuhn V，Diederich L，Keller TCST，et al. Red blood cell function and dysfunction：redox regulation，nitric oxide metabolism，anemia [J]. Antioxid Redox Signal，2017，26（13）：718-742.
[8] Ayi K，Lu Z，Serghides L，et al. CD47-SIRPalpha interactions regulate macrophage uptake of plasmodium falciparum-infected erythrocytes and clearance of malaria in vivo [J]. Infect Immun，2016，84（7）：2002-2011.
[9] Gao W，Zhang L. Engineering red-blood-cell-membrane-coated nanoparticles for broad biomedical applications [J]. AIChE J，2015，61（3）：738-746.
[10] Hu CM，Fang RH，Luk BT，et al. Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach [J]. Nanoscale，2013， 5（7）：2664-2668.
[11] Chen W，Zeng K，Liu H，et al. Cell membrane camouflaged hollow prussian blue nanoparticles for synergistic photothermal-/chemotherapy of cancer [J]. Adv Funct Mater，2017，27（11）：1605795.
[12] Su J，Sun H，Meng Q，et al. Long circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancer [J]. Adv Funct Mater，2016， 26（8）：1243-1252.
[13] Rao L，Bu LL，Xu JH，et al. Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance [J]. Small，2015， 11（46）：6225-6236.
[14] Rao L，Cai B，Bu LL，et al. Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy [J]. ACS Nano，2017，11（4）：3496-3505.
[15] Gao M，Liang C，Song X，et al. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy [J]. Adv Mater，2017，29（35）：1701429.
[16] Singh R，Norret M，House MJ，et al. Dose-dependent therapeutic distinction between active and passive targeting revealed using transferrin-coated PGMA nanoparticles [J]. Small，2016，12（3）：351-359.
[17] Narain A，Asawa S，Chhabria V，et al. Cell membrane coated nanoparticles：next-generation therapeutics [J]. Nanomedicine（Lond），2017，12（21）：2677-2692.
[18] Fang RH，Hu CMJ，Luk BT，et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery [J]. Nano Lett，2014，14（4）：2181-2188.
[19] Chen Z，Zhao P，Luo Z，et al. Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy [J]. ACS Nano，2016，10（11）：10049-10057.
[20] Zhu JY，Zheng DW，Zhang MK，et al. Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes [J]. Nano Lett，2016，16（9）：5895-5901.
[21] Li SY，Cheng H，Xie BR，et al. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy [J]. ACS Nano，2017， 11（7）：7006-7018.
[22] Tian H，Luo Z，Liu L，et al. Cancer cell membrane-biomimetic oxygen nanocarrier for breaking hypoxia-induced chemoresistance [J]. Adv Funct Mater，2017，27（38）：1703197.
[23] Xuan M，Shao J，Dai L，et al. Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo cancer therapy [J]. Advanced Healthcare Materials，2015， 4（11）：1645-1652.
[24] Krishnamurthy S，Gnanasammandhan MK，Xie C，et al. Monocyte cell membrane-derived nanoghosts for targeted cancer therapy [J]. Nanoscale，2016，8（13）：6981-6985.
[25] Kang T，Zhu Q，Wei D，et al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis [J]. ACS Nano，2017，11（2）：1397-1411.
[26] Gujrati V，Kim S，Kim SH，et al. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy [J]. ACS Nano，2014，8（2）：1525-1537.
[27] Parodi A，Quattrocchi N，Van De Ven AL，et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions [J]. Nat Nanotechnol，2013，8（1）：61-68.
[28] Jenne CN，Kubes P. Platelets in inflammation and infection [J]. Platelets，2015，26（4）：286-292.
[29] Thomas MR，Storey RF. The role of platelets in inflammation [J]. Thromb Haemost，2015，114（3）：449-458.
[30] Hu CM，Fang RH，Wang KC，et al. Nanoparticle biointerfacing by platelet membrane cloaking [J]. Nature，2015，526（7571）：118-121. |
|
|
|
